Kato Tadafumi
Aging and Psychiatric Research Group, Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Wako, Saitama, Japan.
Drug News Perspect. 2006 Dec;19(10):597-602. doi: 10.1358/dnp.2006.19.10.1068006.
Altered energy metabolism and accumulated mitochondrial DNA (mtDNA) mutations in the brain, associated mtDNA polymorphisms/mutations or nuclear encoded mitochondrial genes, effects of mood stabilizers on mitochondria and comorbidity of mood disorders with mitochondrial disorders, together suggest the role of mitochondrial dysfunction in the pathophysiology of bipolar disorder. Mitochondrial dysfunction may be involved in the calcium signaling abnormality found in bipolar disorder. We recently produced mice accumulating neuron-specific mtDNA deletions. Bipolar disorder-like behavioral phenotypes of these mice supported this hypothesis. Thus, development of new mood stabilizers acting on mitochondrial function might be warranted.
大脑中能量代谢改变、线粒体DNA(mtDNA)突变积累、相关的mtDNA多态性/突变或核编码线粒体基因、心境稳定剂对线粒体的作用以及心境障碍与线粒体疾病的共病现象,共同提示线粒体功能障碍在双相情感障碍病理生理学中的作用。线粒体功能障碍可能与双相情感障碍中发现的钙信号异常有关。我们最近培育出了积累神经元特异性mtDNA缺失的小鼠。这些小鼠的双相情感障碍样行为表型支持了这一假说。因此,开发作用于线粒体功能的新型心境稳定剂可能是必要的。